209 related articles for article (PubMed ID: 2987413)
1. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
Segonzac A; Schoemaker H; Tateishi T; Langer SZ
J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
[TBL] [Abstract][Full Text] [Related]
2. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
[TBL] [Abstract][Full Text] [Related]
3. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
[TBL] [Abstract][Full Text] [Related]
4. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
Marcusson J; Tiger G
J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of [3H]imipramine binding and [3H]5-HT uptake in human platelets by some natural indoleamine and catecholamine aldehyde condensation products.
Brusov OS; Fomenko AM; Katasonov AB
Eur J Pharmacol; 1984 Aug; 103(1-2):191-2. PubMed ID: 6090176
[No Abstract] [Full Text] [Related]
6. [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: in rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sites.
Barbaccia ML; Melloni P; Pozzi O; Costa E
Eur J Pharmacol; 1986 Apr; 123(1):45-52. PubMed ID: 3011457
[TBL] [Abstract][Full Text] [Related]
7. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
[TBL] [Abstract][Full Text] [Related]
8. [3H]-5-methoxytryptoline is not actively accumulated by rabbit platelets.
Segonzac A; Schoemaker H; Lee CR; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):1-4. PubMed ID: 3627287
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-binding sites in brain and platelets.
Langer SZ; Galzin AM; Lee CR; Schoemaker H
Ciba Found Symp; 1986; 123():3-29. PubMed ID: 3816412
[TBL] [Abstract][Full Text] [Related]
10. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
Hrdina PD
Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
[TBL] [Abstract][Full Text] [Related]
11. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
Kamal LA; Raisman R; Meyer P; Langer SZ
Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
[TBL] [Abstract][Full Text] [Related]
12. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
[TBL] [Abstract][Full Text] [Related]
13. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
Davis A; Morris JM; Tang SW
Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
[TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
Phillips OM; Wood KM; Williams DC
J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
[TBL] [Abstract][Full Text] [Related]
15. Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers.
Segonzac A; Tateishi T; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):33-7. PubMed ID: 6514017
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
[TBL] [Abstract][Full Text] [Related]
17. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
Lesnichuk SA; Katukov VIu; Porodenko NV
Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
[TBL] [Abstract][Full Text] [Related]
18. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
Wölfel R; Graefe KH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
[TBL] [Abstract][Full Text] [Related]
19. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
[TBL] [Abstract][Full Text] [Related]
20. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
